Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: The cancer-DACUS study

Mariasanta Napolitano, Giorgia Saccullo, Alessandra Malato, Delia Sprini, Walter Ageno, Davide Imberti, Doris Mascheroni, Eugenio Bucherini, Pina Gallucci, Andrea D'Alessio, Tullia Prantera, Pietro Spadaro, Stefano Rotondo, Pierpaolo Di Micco, Vincenzo Oriana, Oreste Urbano, Francesco Recchia, Angelo Ghirarduzzi, Lucio Lo Coco, Salvatrice MancusoAlessandra Casuccio, Giovam Battista Rini, Sergio Siragusa

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: The cancer-DACUS study'. Together they form a unique fingerprint.

Medicine & Life Sciences